American Oncology Network Inc. Reports Over 40% Revenue Growth, Surpassing $2 Billion for 12 Months Ending June 30, 2025

Reuters
08/12
<a href="https://laohu8.com/S/AONC">American Oncology Network</a> Inc. Reports Over 40% Revenue Growth, Surpassing $2 Billion for 12 Months Ending June 30, 2025

American Oncology Network Inc. $(AON)$ has reported strong financial results for the 12 months ended June 30, 2025, with annual revenue surpassing $2 billion. This represents a growth of over 40% compared to the previous 12-month period ending June 30, 2024. The increase in revenue is attributed to both organic expansion and the integration of new practices and providers in various markets. AON's provider network has expanded to over 300 oncology and hematology providers across 20 states, enhancing access to advanced treatment options. In terms of business operations, AON continues to invite new partners to join its network, promoting clinical autonomy and increased revenue through access to its comprehensive support infrastructure. Partner practices have experienced an average of more than 30% increase in sustainable income after joining AON. Looking forward, AON has shown leadership in value-based care by achieving nearly $6 million in cost savings for CMS and partnering with a multi-state commercial value-based care organization, resulting in $2.7 million in cumulative savings. Additionally, AON launched a self-funded employer contracting initiative covering 1 million lives, aligned with value-based benefit design principles, and implemented a social risk navigation platform that improved social risk factors by 39%, contributing to better health outcomes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on August 12, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10